[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353479-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353479-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","differences-between-mitotically-old-and-young-endometrial-tumors","Differences between mitotically old and young endometrial tumors","","Human tumors likely differ in mitotic ages, reflecting how many cell divisions occur between the last tumor progenitor cell and surgical removal. Using a rapidly fluctuating CpG (fCpG) methylation clock, researchers inferred relative mitotic ages of endometrial adenocarcinomas. Young tumors showed low-diversity, high-variance fCpG patterns with trimodal peaks, while older tumors showed higher diversity, lower variance, and unimodal profiles. Mitotic ages varied across samples, with TCGA tumors linking younger cases to proliferation pathways and older cases to immune infiltration and T-cell exhaustion. Results support ranking cancers by mitotic age and suggest immune surveillance restrains older growth.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/differences-between-mitotically-old-and-young-endometrial-tumors/353479/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/differences-between-mitotically-old-and-young-endometrial-tumors/353479.png","ImageObject",300,407,{"name":42,"@type":43},"moss~","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is tumor mitotic age defined in the study?","Question",{"text":63,"@type":64},"Tumor mitotic age represents the number of cell divisions between a final progenitor cell and tumor removal. Differences in this age may relate to important clinical and biological behavior.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What method was used to estimate mitotic ages?",{"text":68,"@type":64},"The study used a molecular clock approach based on diversity of DNA methylation at fluctuating CpG sites (fCpGs). The fCpG clock is reset to the progenitor’s methylation pattern during clonal expansion.",{"name":70,"@type":61,"acceptedAnswer":71},"How do fCpG methylation patterns differ between young and older endometrial tumors?",{"text":72,"@type":64},"Young tumors show low-diversity, high-variance fCpG distributions with trimodal peaks near 0%, 50%, and 100%. Older tumors show higher diversity, lower variance, and unimodal distributions centered around 50%.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353479,1790387501,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of Pathology  \nJ Pathol October 2026; 270: 163–173  \nPublished online 8 July 2026 in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com) DOI: 10.1002/path.70090)[)](leyonlinelibrary.com) DOI: 10.1002/path.70090)[ DOI:](leyonlinelibrary.com) DOI: 10.1002/path.70090)[ 10.1002/path.70090](leyonlinelibrary.com) DOI: 10.1002/path.70090)  \nORIGINAL ARTICLE  \nDifferences between mitotically old and young endometrial tumors Kellie Kim and Darryl Shibata*  \nDepartment of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA  \n*Correspondence to: D Shibata, Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA. [E-mail:](E-mail: dshibata@usc.edu)[ dshibata@usc.edu](E-mail: dshibata@usc.edu)  \nAbstract  \nHuman tumors likely differ in their mitotic ages, reﬂecting how many divisions elapse between the ﬁnal tumor progenitor cell and surgical removal. We used a rapidly ﬂuctuating CpG (fCpG) methylation clock to infer relative endometrial adenocarcinomas (EAC) mitotic ages. Experimentally, young tumors initiated from single cells show low-diversity, high-variance fCpG distributions with trimodal peaks near 0%, 50%, and 100%, reﬂecting inherited progenitor methylation states. fCpG methylation becomes polymorphic with divisions, and older tumors exhibit higher diversity, lower variance, and unimodal distributions centered around 50%. Mitotic ages varied across EAC samples. Synchronous hyperplasia and invasive regions generally shared similar ages, and primary–metastatic EAC pairs showed both synchronous and stepwise progression. The Cancer Genome Atlas (TCGA) EACs also showed variable mitotic ages: younger tumors were enriched for proliferation pathways, whereas older tumors showed more immune inﬁ ltration, immune-pathway activation, and evidence ofT-cell exhaustion. These results show that human tumors can be ranked by mitotic age and suggest that the growth of older cancers is restrained by immune surveillance.  \n© 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great  \nBritain and Ireland.  \nKeywords: mitotic age; endometrial adenocarcinoma; DNA methylation; epigenetic clock; tumor evolution; immune surveillance; T-cell exhaustion  \nReceived 30 December 2025; Revised 3 March 2026; Accepted 28 May 2026 No conﬂicts of interest were declared.  \nIntroduction  \nTumor mitotic age can be deﬁned as the numbers of cell divisions between a ﬁnal progenitor cell and tumor removal (Figure 1A) . Tumor mitotic ages may differ, and there may be important clinical and biological differences between very young and older cancers. Understanding why some cancers require many more divisions before detection and removal may help identify mechanisms that naturally restrain tumor growth. The minimum age for a detectable tumor (a billion cells) is about 30 divisions (230) . Additional divisions are required if tumor cells are removed during growth, which may occur when the tumor microenvironment (TME) cannot sustain proliferation or when cells are actively eliminated by processes such as immunoediting [1]. Currently there are no robust methods to infer human cancer mitotic ages. Here we use a molecular clock approach to estimate population ages based on genomic diversity, under the principle that cells in older populations are more polymorphic (Figure 1B).  \nHuman tumor evolution is commonly reconstructed from somatic mutations [2–4], but it is technically difﬁcult to measure tumor genetic diversity because most detectable subclonal mutations (≥ 5% allele frequency)  \narise early, when the tumor is still very small [5] . For example, a new subclonal mutation in a tumor of only around 106 cells would be present in \u003C 0 .0001 of the population and therefore undetectable by conventional sequencing.  \nHere we use the diversity of DNA methylation at ﬂuctuating CpG sites (fCpGs [6]) t","cbCaigr2ELvL7D6o","https://ap.wps.com/l/cbCaigr2ELvL7D6o","pdf",8248208,11,"English","# Introduction\n## Mitotic age concept and clinical relevance\n## Limits of genetic diversity approaches\n## fCpG methylation clock rationale and mechanism","[{\"question\":\"How is tumor mitotic age defined in the study?\",\"answer\":\"Tumor mitotic age represents the number of cell divisions between a final progenitor cell and tumor removal. Differences in this age may relate to important clinical and biological behavior.\"},{\"question\":\"What method was used to estimate mitotic ages?\",\"answer\":\"The study used a molecular clock approach based on diversity of DNA methylation at fluctuating CpG sites (fCpGs). The fCpG clock is reset to the progenitor’s methylation pattern during clonal expansion.\"},{\"question\":\"How do fCpG methylation patterns differ between young and older endometrial tumors?\",\"answer\":\"Young tumors show low-diversity, high-variance fCpG distributions with trimodal peaks near 0%, 50%, and 100%. Older tumors show higher diversity, lower variance, and unimodal distributions centered around 50%.\"}]","Differences between mitotically old and young endometrial tumors | PDF",1790105643,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15823277d5264775df592937ca2420d5.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1cd88e914c93d7f01a357d53bd67f8e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0aa36d9cbaae64ccc540c62a76796ad2.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c92c96377b034664d64f803754c3a823.webp",980,1385]